HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$14.24
Day range
$13.77 - $14.35
Year range
$8.24 - $18.37
Market cap
912.45M USD
Avg Volume
864.47K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 44.45M | 25.69% |
Net income | -42.21M | -33.97% |
Net profit margin | — | — |
Earnings per share | -0.79 | -12.86% |
EBITDA | -44.43M | -25.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 343.03M | 1.32% |
Total assets | 354.94M | 2.22% |
Total liabilities | 13.39M | -30.30% |
Total equity | 341.56M | — |
Shares outstanding | 65.18M | — |
Price to book | 2.71 | — |
Return on assets | -39.62% | — |
Return on capital | -41.71% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -42.21M | -33.97% |
Cash from operations | -45.49M | -137.67% |
Cash from investing | -92.88M | -65.99% |
Cash from financing | 189.28M | 62.88% |
Net change in cash | 50.92M | 23.84% |
Free cash flow | -29.70M | -326.83% |
About
Founded
2019
Website
Employees
51
